All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings

We evaluated treatment outcomes in a prospective registry of human immunodeficiency virus/hepatitis C virus (HCV)–coinfected patients treated with interferon‐free direct‐acting antiviral agent–based therapy in hospitals from the region of Madrid between November 2014 and August 2016. We assessed sus...

Descripción completa

Detalles Bibliográficos
Autores principales: Berenguer, Juan, Gil‐Martin, Ángela, Jarrin, Inmaculada, Moreno, Ana, Dominguez, Lourdes, Montes, Marisa, Aldámiz‐Echevarría, Teresa, Téllez, María J., Santos, Ignacio, Benitez, Laura, Sanz, José, Ryan, Pablo, Gaspar, Gabriel, Alvarez, Beatriz, Losa, Juan E., Torres‐Perea, Rafael, Barros, Carlos, Martin, Juan V. San, Arponen, Sari, de Guzmán, María T., Monsalvo, Raquel, Vegas, Ana, Garcia‐Benayas, María T., Serrano, Regino, Gotuzzo, Luis, Menendez, María Antonia, Belda, Luis M, Malmierca, Eduardo, Calvo, María J., Cruz‐Martos, Encarnación, González‐García, Juan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055848/
https://www.ncbi.nlm.nih.gov/pubmed/29377274
http://dx.doi.org/10.1002/hep.29814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055848/
https://www.ncbi.nlm.nih.gov/pubmed/29377274
http://dx.doi.org/10.1002/hep.29814

Ejemplares similares